CVS Health (CVS) Tops Q4 EPS by 7c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $79.96 -12.53%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
ARIS, COHR, ATS, More
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
ARIS, COHR, ATS, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.99, $0.07 better than the analyst estimate of $1.92. Revenue for the quarter came in at $83.85 billion versus the consensus estimate of $76.33 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.70-$8.90, versus the consensus of $8.86.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Sturm Ruger (RGR) Tops Q3 EPS by 7c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
